CDK9 and atherosclerosis: In this study, atherosclerosis model was established in apolipoprotein E null mice (ApoE-/-) fed with high fat diet (HFD), and a highly specific small-molecule CDK9 inhibitor, LDC000067, was utilized to treat the atherosclerotic mice.